BlueChili HealthTech Accelerator takes place in Singapore, featuring startups that seek to tackle mental health to chronic disease issues in Southeast Asia

BlueChili, a venture group headquartered in Australia and Singapore, announces the 10 healthtech startups it has discovered and selected to join BlueChilli HealthTech Accelerator in Singapore. The programme is developed in partnership with Enterprise Singapore, announced in May this year.

Joining the programme, BlueChili will give founders access to its venture studio to help them advance their products, scale their customer base, secure investments, and expand their teams.

BlueChilli said it will provide its network of programme partners and industry advisors from leading corporations and stakeholders across healthcare providers, pharmaceutical companies, science and research institutions, investors, consulting firms and scale-ups across Singapore and Australia.

“The early-stage startups selected for the programme are tackling issues in mental health, chronic disease, preventive care, and efficiency of small health service providers – and we believe in their potential to improve health outcomes in the region,” said BlueChilli programme director Seow Hui Hong.

Also Read: Understand the context of Southeast Asia: BlueChilli wants to buoy healthtech startups

The first startups invited to join the programme include:

● Safe Space, improving access to early intervention and sustainable therapy support for mental health issues with a mobile-first solution powered with AI-enabled chatbot, on-demand 24/7.

● Advanx Health, the company focusses on preventive health and enabling personalised care through genomics. From providing individuals with insights and solutions based on their genetic profile, they are now focussed on growing their health and wellness offerings for individuals to follow-up in improving their targeted health concerns.

● Xenomites is on a mission to free the population from the most common source of Hay Fever in Southeast Asia without drugs by working on a product to efficiently deliver a proprietary, clinically-proven mix of agents to drastically reduce dust mite colonies in home and community settings.

● Reemedy, increasing efficiency of the supply chain for small healthcare providers so clinicians can focus on delivering quality primary care using a B2B procurement platform and marketplace that provide real-time pricing and transparent access to medical supplies with reviews from fellow practitioners and providers, integrated with clinic management software.

The startups were selected for the programme based on the founders’ vision and capabilities to advance ideas in improving health in Southeast Asia, as well as the founder fit for the programme to make the most impact in realising their startups’ potential.

The programme is supported by partners CSIRO, Galen Growth Asia, Mercer, Resmed and The Working Capitol and will kick off on January 2020. It will commence with Investor Showcase where the startups will pitch to a room of leading investors from across APAC.
–

Image Credit: BlueChili

The post BlueChilli introduces the healthtech startups selected into its accelerator appeared first on e27.